Eczematoid dermatitis (Phenotype)

Synonyms:HP:0000976, HP:0001481, Eczema
Id:HP:0000964
Description:Eczema is a form of dermatitis that is characterized by scaly, pruritic, erythematous lesions located on flexural surfaces.
Results found

Linked to

 

Label

Description

 

Gene

ENSG00000144908 - aldehyde dehydrogenase 1 family member L1

Gene

ENSG00000231939 - major histocompatibility complex, class II, DQ beta 1 [Source:HGNC Symbol;Acc:HGNC:4944]

Gene

ENSG00000231676 - olfactory receptor family 2 subfamily J member 2 [Source:HGNC Symbol;Acc:HGNC:8260]

Gene

ENSG00000204539 - corneodesmosin

Gene

ENSG00000147654 - estrogen receptor binding site associated antigen 9

Gene

ENSG00000223793 - major histocompatibility complex, class II, DQ alpha 2 [Source:HGNC Symbol;Acc:HGNC:4943]

Gene

ENSG00000159267 - holocarboxylase synthetase

Gene

ENSG00000135114 - 2'-5'-oligoadenylate synthetase like

Gene

ENSG00000228284 - major histocompatibility complex, class II, DQ alpha 1 [Source:HGNC Symbol;Acc:HGNC:4942]

Gene

ENSG00000100154 - tetratricopeptide repeat domain 28

  • Gene

    ENSG00000144908 - aldehyde dehydrogenase 1 family member L1


  • Gene

    ENSG00000231939 - major histocompatibility complex, class II, DQ beta 1 [Source:HGNC Symbol;Acc:HGNC:4944]


  • Gene

    ENSG00000231676 - olfactory receptor family 2 subfamily J member 2 [Source:HGNC Symbol;Acc:HGNC:8260]


  • Gene

    ENSG00000204539 - corneodesmosin


  • Gene

    ENSG00000147654 - estrogen receptor binding site associated antigen 9


  • Gene

    ENSG00000223793 - major histocompatibility complex, class II, DQ alpha 2 [Source:HGNC Symbol;Acc:HGNC:4943]


  • Gene

    ENSG00000159267 - holocarboxylase synthetase


  • Gene

    ENSG00000135114 - 2'-5'-oligoadenylate synthetase like


  • Gene

    ENSG00000228284 - major histocompatibility complex, class II, DQ alpha 1 [Source:HGNC Symbol;Acc:HGNC:4942]


  • Gene

    ENSG00000100154 - tetratricopeptide repeat domain 28

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.